Jing-yu Hou
Guangdong Provincial Key Laboratory Of Translational Medicine In Lung Cancer, No. 106 Zhongshan 2 Road
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Adjuvant immunotherapy may have no impact on survival in patients who received neoadjuvant immunotherapy for stage II-IIIB non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 18, 2026
ELABELA promotes the migration and homing of bone marrow mesenchymal stem cells to myocardial injury sites through the ERK1/2/miR-299a-5p/Exo70 pathway.
Journal: Frontiers in pharmacology
Published: December 08, 2024
Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway.
Journal: Cellular and molecular neurobiology
Published: March 03, 2023
Real-Life Experience of Regorafenib in Patients With Advanced Hepatocellular Carcinoma.
Journal: Frontiers in pharmacology
Published: April 11, 2022
Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection.
Journal: Journal of gastroenterology
Published: August 31, 2021
Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients.
Journal: Journal of cancer research and clinical oncology
Published: July 07, 2019
Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma.
Journal: Annals of surgical oncology
Published: September 22, 2018
Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: July 18, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026